# Sodium Hyaluronate and Wavefront Aberrations in Dry Eyes

> **NCT01363414** · NA · COMPLETED · sponsor: **Ramathibodi Hospital** · enrollment: 50 (actual)

## Conditions studied

- Dry Eye

## Interventions

- **DRUG:** 0.18% sodium hyaluronate
- **DRUG:** 0.9% sodium chloride solution

## Key facts

- **NCT ID:** NCT01363414
- **Lead sponsor:** Ramathibodi Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-01
- **Primary completion:** 2010-06
- **Final completion:** 2010-09
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2011-06-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01363414

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01363414, "Sodium Hyaluronate and Wavefront Aberrations in Dry Eyes". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01363414. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*